查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1470966

静脉液市场：按类型、成分、最终用户划分 - 全球预测 2024-2030

Intravenous Solutions Market by Type (Peripheral Parenteral Nutrition, Total Parenteral Nutrition), Composition Solution (Carbohydrates, Dextran, Heparin & Trace Element), End-users - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年静脉输液市场规模为137.6亿美元，预计2024年将达149.9亿美元，2030年将达253.8亿美元，复合年增长率为9.13%。

静脉输液是设计用于经由静脉导管直接注射病人静脉循环的无菌液体，通常用于补水、矫正电解质失衡、给药和输血。静脉输液的成分根据预期目的而有很大差异，包括等渗透压、高渗透压和低渗透压溶液，每种溶液都是为了实现特定的治疗目标而定制的。主要成分通常包括生理食盐水、葡萄糖、电解质，有时还包括维生素和药物。仔细选择和管理静脉输液对于急性和慢性医疗机构的患者照护至关重要。了解静脉输液的正确处方和正确使用对于确保有效的治疗结果和病人安全至关重要。静脉输液市场的推动因素包括慢性病盛行率的不断上升、手术数量的增加以及全球静脉製剂监管机构批准的增加。然而，静脉输液的技术限制和对熟练人员的需求对其采用提出了挑战。提高静脉输液效率和安全性的进步和研究倡议为静脉输液市场的扩张提供了利润丰厚的成长机会。

主要市场统计
基准年[2023] 137.6亿美元
预测年份 [2024] 149.9亿美元
预测年份 [2030] 253.8亿美元
复合年增长率（%） 9.13%

由于营养和代谢需求的增加，全身肠外营养的使用正在扩大。

週边肠外营养（PPN）透过週边静脉施用，通常用于需要短期营养支持或营养需求适中的患者。 PPN 的溶液浓度比 TPN 低，通常在必须避免留置中央静脉导管引起併发症的风险时使用。 PPN 溶液通常是溶解在无菌水中的蛋白质、碳水化合物、维生素和矿物质。确切的成分根据患者的营养需求、医疗状况、体重和液体耐受性进行调整。通常含有脂肪以提供必需脂肪酸和热量。全身肠外营养（TPN）直接注射到中央静脉系统，允许施用高浓度的营养物质。此方法适用于营养需求高的患者、有胃肠道併发症的患者、需要长期营养支持的患者。 TPN 可以完全绕过消化器官系统，将您所需的所有营养物质（包括碳水化合物、蛋白质、脂肪、维生素和矿物质）直接输送到您的血液中。

最终用户医院和诊所不断增长的需求满足了广泛的患者需求

在门诊手术中心，静脉输液对于控製手术过程中的水合和稳定性至关重要，它们还可以作为药物给药的载体，包括麻醉剂和镇静剂，在可能的情况下提供必要的营养支持。在医院和诊所等各种医疗保健环境中，静脉输液对于各种应用至关重要，从创伤或休克情况下的紧急液体復苏到专业部门的输血和化疗的药物管理。静脉输液对于静脉输液管理水合和稳定性至关重要，在支持慢性病患者和老年患者的长期照护环境中也同样重要，因为在这些环境中，水合、药物管理和口服摄取有利于患者的肠外营养。专科诊所利用静脉注射解决方案进行特定治疗，例如透析中的电解质平衡、疼痛管理以及荷尔蒙替代等标靶治疗，以提供精确和受控的护理。

区域洞察

由于先进的医疗设施和行业领先的公司的存在，以美国为首的美国静脉输液市场正在扩大。需求显着激增是由于癌症、糖尿病和胃肠道疾病等慢性疾病的增加。美洲地区专注于研发，促进创新产品的推出。在可支配收入增加、医疗保健框架扩大和健康意识不断增强的推动下，亚太地区市场预计将出现快速成长，尤其是在中国和印度等成长中的经济体。在政府改善医疗基础设施和实施市场友善政策的支持下，亚太地区庞大的人口也为静脉输液市场的扩张提供了巨大的机会。欧洲、中东和非洲地区保持稳定成长，欧洲拥有完善的医疗保健系统、高度的病患意识和严格的监管标准。预计中东和非洲地区将出现温和成长，这主要是由于波湾合作理事会（GCC）国家和南非活性化的医疗基础设施投资以及对医疗服务的需求不断增长。

FPNV定位矩阵

FPNV定位矩阵对于评估静脉输液市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对静脉液市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.静脉输液市场规模及预测如何？

2.静脉液市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3. 静脉输液市场的技术趋势和法规结构是什么？

4.静脉输液市场主要供应商的市场占有率为何？

5.进入静脉输液市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 胃肠道疾病、癌症和神经系统疾病等慢性和急性疾病的发生率增加
      • 增加静脉输液的监管核准
      • 加强製造商之间的策略合作以增强产品系列
    • 抑制因素
      • 流体维护成本高
    • 机会
      • 新兴经济体对静脉输液的需求增加
      • 为患者提供便利的产品改进和新创新
      • 维生素C滴注在结直肠癌患者的实施
    • 任务
      • 静脉输液的副作用
  • 市场区隔分析
    • 类型：不断增长的营养和代谢需求扩大了全肠外营养的使用
    • 最终使用者：医院和诊所的需求不断增加，以满足广大病患的需求
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章 静脉液市场：依类型

  • 週边肠外营养
  • 全肠外营养

第七章 静脉液体市场构成方案

  • 碳水化合物
  • 聚葡萄糖
  • 肝素和微量元素
  • 肠外脂肪乳剂
  • 单剂量氨基酸溶液
  • 维生素和矿物质

第八章静脉液体市场：依最终使用者分类

  • 门诊手术中心
  • 医院/诊所
  • 长期照护设施
  • 专科诊所

第九章 北美、南美静脉输液市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太静脉液体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲静脉注射液市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Hikma 宣布在美国发布 COMBOGESIC IV
    • Sanjivani Palantral Limited 与 HAL 合作生产静脉注射製剂和静脉注射套件
    • CTMUHB 和 Baxter 合作实现更安全的静脉输液
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-710B1F0AC675

[194 Pages Report] The Intravenous Solutions Market size was estimated at USD 13.76 billion in 2023 and expected to reach USD 14.99 billion in 2024, at a CAGR 9.13% to reach USD 25.38 billion by 2030.

Intravenous solutions are sterile liquids designed to be administered directly into the venous circulation of a patient via an IV catheter and are commonly used for fluid replacement, correcting electrolyte imbalances, delivering medications, and blood transfusions. The composition of intravenous solutions can vary widely depending on their intended purpose, including isotonic, hypertonic, and hypotonic solutions, each tailored to achieve specific therapeutic objectives. Key constituents often include saline, dextrose, electrolytes, and sometimes vitamins or medications. Careful selection and administration of Intravenous solutions are critical for patient care in acute and chronic medical settings. Understanding the precise formulation and appropriate use of intravenous solutions is foundational to ensuring effective treatment outcomes and patient safety. The intravenous solutions market is driven by an increasing prevalence of chronic diseases, rising incidences of surgeries, and rising regulatory approvals for intravenous formulations globally. However, technical limitations of intravenous solutions and the need for skilled personnel pose a challenge to adopting intravenous solutions. Advancements and research initiatives to improve the efficiency and safety of intravenous fluids are offering lucrative growth opportunities for the Intravenous solutions market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 13.76 billion
Estimated Year [2024] USD 14.99 billion
Forecast Year [2030] USD 25.38 billion
CAGR (%) 9.13%

Type: Widening use of total parenteral nutrition owing to rising nutritional and metabolic needs

Peripheral parenteral nutrition (PPN) is administered through a peripheral vein, typically for patients requiring nutritional support for a short period or when the nutritional requirement is not very high. PPN is a less concentrated solution than TPN and is often used when the risk of complications from central venous catheterization must be avoided. PPN solutions generally contain proteins, carbohydrates, vitamins, and minerals dissolved in sterile water. The precise composition is adjusted based on the nutritional needs of patients, medical conditions, body weight, and fluid tolerance. Lipids are often included to provide essential fatty acids and calories. Total parenteral nutrition (TPN) is delivered directly into the central venous system, allowing for a higher concentration of nutrients to be administered. This method is suitable for patients with significant nutritional needs, gastrointestinal complications, and for those who require long-term nutritional support. TPN can completely bypass the digestive system, directly providing all necessary nutrients such as carbohydrates, proteins, fats, vitamins, and minerals into the bloodstream.

End-Users: Rising demand from hospitals & clinics to cater to a broad spectrum of patient needs

In ambulatory surgical centers, intravenous solutions are indispensable for fluid replacement to manage hydration and stability during surgeries and also function as vehicles for medication administration, including anesthetics and sedatives, and provide essential nutritional support when oral intake is not feasible. In more extensive healthcare settings, such as hospitals and clinics, IV solutions are vital for various uses, from emergency fluid resuscitation in trauma or shock cases, and medication delivery to blood transfusions and chemotherapy in specialized departments. Intravenous solutions are indispensable for fluid replacement to manage hydration and stability du are equally crucial in long-term care settings for the support of chronically ill or elderly patients, facilitating hydration, medication management, and parenteral nutrition for those unable to consume food orally. Specialty clinics harness IV solutions for specific treatments such as electrolyte balancing in dialysis, pain management, and targeted therapies such as hormone replacements, ensuring precise and controlled care delivery.

Regional Insights

In the Americas, the intravenous solutions market is expanding, with the United States at the forefront due to its advanced healthcare facilities and the presence of leading industry players. A notable demand surge is attributed to the rising cases of chronic diseases such as cancer, diabetes, and gastrointestinal disorders. The Americas benefits from a strong focus on research and development, fostering the introduction of innovative products. The Asia-Pacific region is poised for the fastest market growth, propelled by increasing disposable incomes, expanding healthcare framework, and heightened health awareness, particularly in growing economies such as China and India. The extensive population in the Asia-Pacific region also offers vast opportunities for the intravenous solutions market expansion, supported by government efforts to improve healthcare infrastructure and implement market-friendly policies. The EMEA region maintains steady growth, with Europe having sophisticated healthcare systems, high levels of patient awareness, and stringent regulatory standards. The Middle East and Africa are projected to witness moderate growth, primarily driven by heightened healthcare infrastructure investments and a growing demand for healthcare services in Gulf Cooperation Council (GCC) countries and South Africa.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Intravenous Solutions Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intravenous Solutions Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Intravenous Solutions Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., Amanta Healthcare Ltd., Anhui Medipharm Co. Ltd, Axa Parenterals Ltd, B. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson and Company, Enzymes Pharmaceuticals, Eurolife Healthcare Pvt. Ltd., Fresenius SE & Co. KGaA, Grifols, S.A., ICU Medical, Inc., JW Life Science Corporation, Lxir Medilabs Pvt. Ltd., Nymak Pharma Ltd., Otsuka Holdings Co., Ltd., Pfizer Inc., Salius Pharma Private Limited, Schwitz Biotech, Sichuan Kelun Pharmaceutical Co., Ltd., Soxa Formulations & Research Pvt. Ltd., Terumo Corporation, Trumac Healthcare, Varni Corporation, and Vifor Pharma Management Ltd..

Market Segmentation & Coverage

This research report categorizes the Intravenous Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Peripheral Parenteral Nutrition
    • Total Parenteral Nutrition
  • Composition Solution
    • Carbohydrates
    • Dextran
    • Heparin & Trace Element
    • Parenteral Lipid Emulsion
    • Single Dose Amino Acid Solution
    • Vitamins & Minerals
  • End-users
    • Ambulatory Surgical Centers
    • Hospitals & Clinics
    • Long-term Care Facilities
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Intravenous Solutions Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intravenous Solutions Market?

3. What are the technology trends and regulatory frameworks in the Intravenous Solutions Market?

4. What is the market share of the leading vendors in the Intravenous Solutions Market?

5. Which modes and strategic moves are suitable for entering the Intravenous Solutions Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the Incidence of Chronic and Acute Diseases such as Gastrointestinal Disorder, Cancer, and Neurological Diseases
      • 5.1.1.2. Increasing Regulatory Approvals for Intravenous Solution Injections
      • 5.1.1.3. Rise in Strategic Collaborations Between Manufacturers to Enhance their Product Portfolio
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of Maintenance of Fluids
    • 5.1.3. Opportunities
      • 5.1.3.1. Increase in Demand for Intravenous Solutions from Developing Economies
      • 5.1.3.2. Improvements and New Innovations in the Products for Patient Convenience
      • 5.1.3.3. Implementation of Vitamin C Intravenous for Patients with Colorectal Cancer
    • 5.1.4. Challenges
      • 5.1.4.1. Side Effects of Intravenous Fluids
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Widening use of total parenteral nutrition owing to rising nutritional and metabolic needs
    • 5.2.2. End-Users: Rising demand from hospitals & clinics to cater to a broad spectrum of patient needs
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Intravenous Solutions Market, by Type

  • 6.1. Introduction
  • 6.2. Peripheral Parenteral Nutrition
  • 6.3. Total Parenteral Nutrition

7. Intravenous Solutions Market, by Composition Solution

  • 7.1. Introduction
  • 7.2. Carbohydrates
  • 7.3. Dextran
  • 7.4. Heparin & Trace Element
  • 7.5. Parenteral Lipid Emulsion
  • 7.6. Single Dose Amino Acid Solution
  • 7.7. Vitamins & Minerals

8. Intravenous Solutions Market, by End-users

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals & Clinics
  • 8.4. Long-term Care Facilities
  • 8.5. Specialty Clinics

9. Americas Intravenous Solutions Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intravenous Solutions Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intravenous Solutions Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Hikma announces US launch of COMBOGESIC IV
    • 12.3.2. Sanjivani Paranteral Limited and HAL collaborate to manufacture IV formulations and IV Sets
    • 12.3.3. CTMUHB and Baxter partner to implement safer IV fluid administration
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. INTRAVENOUS SOLUTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAVENOUS SOLUTIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INTRAVENOUS SOLUTIONS MARKET DYNAMICS
  • FIGURE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRAVENOUS SOLUTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DEXTRAN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DEXTRAN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HEPARIN & TRACE ELEMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HEPARIN & TRACE ELEMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PARENTERAL LIPID EMULSION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PARENTERAL LIPID EMULSION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SINGLE DOSE AMINO ACID SOLUTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SINGLE DOSE AMINO ACID SOLUTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 291. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 292. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023